Ad
related to: topiramate discontinuation syndrome treatment- Efficacy & Safety Info
Learn More About EPIDIOLEX®
Efficacy & Safety Info.
- Why EPIDIOLEX®
EPIDIOLEX® Is Designed With Your
Patients In Mind. Learn More.
- Efficacy & Safety Info
Search results
Results From The WOW.Com Content Network
A package of topiramate 25mg from Norway. Topiramate is used to treat epilepsy in children and adults, and it was originally used as an anticonvulsant. [19] In children, it is indicated for the treatment of Lennox-Gastaut syndrome, a disorder that causes seizures and developmental delay.
[2] [6] [4] Treatment may include restarting the medication and slowly decreasing the dose. [2] People may also be switched to the long-acting antidepressant fluoxetine which can then be gradually decreased. [6] Approximately 15–50% of people who suddenly stop an antidepressant develop antidepressant discontinuation syndrome.
Clinical data shows that the treatment of choice is abrupt drugs withdrawal, followed by starting prophylactic therapy. [25] However, the discontinuation of overused drugs may lead to the initial worsening of headaches, nausea, vomiting, sleep disturbance, anxiety, and restlessness. [9]
Among bipolar patients taking anticonvulsants, those on lamotrigine have a better cognitive profile than those on carbamazepine, valproate, topiramate, and zonisamide. [36] Although decreased verbal memory and slowed psychomotor speed are common side effects of lithium use [37] [38] these side effects usually disappear after discontinuation of ...
It is considered a distinct phenomenon from antidepressant discontinuation syndrome, post-acute withdrawal syndrome, and major depressive disorder, [70] [68] and should be distinguished from sexual dysfunction associated with depression [70] and persistent genital arousal disorder. [64]
Protracted withdrawal syndrome, also known as post-acute-withdrawal syndrome or "PAWS", is a low-grade continuation of some of the symptoms of acute withdrawal, typically in a remitting-relapsing pattern, often resulting in relapse and prolonged disability of a degree to preclude the possibility of lawful employment. Protracted withdrawal ...
Participants took a weekly 2.4-milligram dose of semaglutide for 68 weeks before stopping the treatment. They also stopped the healthy lifestyle changes they made while taking semaglutide.
Tardive dyskinesia (TD) is an iatrogenic disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips, [1] which occurs following treatment with medication.
Ad
related to: topiramate discontinuation syndrome treatment